ArticleCancers2024

Testing Adaptive Therapy Protocols Using Gemcitabine and Capecitabine in a Preclinical Model of Endocrine-Resistant Breast Cancer.

Sareh Seyedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.